Clinical trial
Continuation of Follow-up of DES-Exposed Cohorts
NCT00340600 · National Cancer Institute (NCI), NIH · Completed
Key facts
| NCT number | NCT00340600 |
|---|---|
| Title | Continuation of Follow-up of DES-Exposed Cohorts |
| Official title | Continuation of Follow-up of DES-Exposed Cohorts |
| Lead sponsor | National Cancer Institute (NCI), NIH |
| Status | Completed |
| Study type | Observational |
| Conditions | Breast Cancer, Autoimmune Disease, Prostate Cancer, Ovarian Cancer, Endometrial Cancer |
| Enrollment | 10,805 |
| Start date | Mar 18, 1998 |
| Primary completion | Sep 30, 2015 |
| Completion | Nov 13, 2020 |
| First posted | Jun 21, 2006 |
| Last update posted | Nov 16, 2020 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: